VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies 2020 | 4-year Horizon 2020 ITN-Marie Curie training network

Troels Jordansen, of Glycostem Therapeutics, Oss, The Netherlands, discusses the 4-year Horizon 2020 ITN-Marie Curie training programme aiming to develop novel methods to manufacture tumor reactive NK cells.This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).